Showing results (191-200 of 233) with videos related to

Sort By:
Pageof 24
Endocrine-Related Cancer|March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinomaJ Hadoux, D Malka, D Planchard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2021
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIsE Felip, A T Shaw, A Bearz, et al.
Revue Des Maladies Respiratoires|June 8, 2011
[Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: tinzaparin in lung tumours]G Meyer, B Besse, S Friard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2014
A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancerS Novello, B Besse, E Felip, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2020
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancerD Planchard, N Reinmuth, S Orlov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOSY-L Wu, D Planchard, S Lu, et al.
Journal of Crohn'S & Colitis|January 20, 2016
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel DiseaseL Marthey, C Mateus, C Mussini, et al.
Respiratory Medicine and Research|June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemicN Girard, L Greillier, G Zalcman, et al.
Lung Cancer (Amsterdam, Netherlands)|June 3, 2020
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer expertsM Früh, C M Panje, M Reck, et al.
Scientific Reports|May 18, 2022
Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platformM Morfouace, S Novello, A Stevovic, et al.
Pageof 24